Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025Blood

A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortium

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMark R. DowlingSIShafqat InamJLJian Li

Discussion

Loading...

Member takes

Overview

Analysis shows improved progression-free survival and lower toxicity in lymphoma patients based on risk factors and bridging strategies.

Key Points

  • Real-world outcomes demonstrate effective CAR-T therapy for relapsed lymphoma, enhancing patient management.
  • Progression-free survival was significantly influenced by risk factors and bridging response strategies.
  • This observational analysis across six Australian centers provides valuable insights into CAR-T outcomes.
  • These findings highlight the importance of patient selection and risk stratification for optimal CAR-T therapy.

Cite This Study

Dowling et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d74chttps://doi.org/10.1182/blood-2025-399
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvement2025
  2. 2Real world chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma: The Australian experience2025
  3. 3Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in Australia.2025
  4. 4Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma—importance of pre-CAR-T optimization2025 · 2 citations
  5. 5Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma2025 · 21 citations